Literature DB >> 21294704

Synthesis and screening of substituted thiosemicarbazone derivatives: an approach towards novel anticonvulsant search.

Priyanka Singh1, Jainendra Jain, Reema Sinha, Abdul Samad, Rajeev Kumar, Manav Malhotra.   

Abstract

A series of thiosemicarbazones of halogen substituted benzaldehydes, benzophenone and acetophenone were synthesized using an appropriate synthetic route and characterized by thin layer chromatography and spectral analysis. The anticonvulsant activity of synthesized compounds was established in three seizures models which includes maximal electroshock (MES), subcutaneous pentylene tetrazole (scPTZ) induced seizures and minimal neurotoxicity test. Five compounds out of 21 exhibited protection in MES test while only one compound showed protection in scPTZ screen. Two compounds were found to be active in minimal clonic seizure (6Hz) model. Compound PS6 i.e. 2-(3-bromobenzylidene)-N-(4-chlorophenyl) hydrazinecarbothioamide emerged as the most active compound with MES ED50 of more than 50mg/kg and pI greater than 12, which is found to be better than the prototype drug, Phenytoin. The compound has shown neuroprotection in kainic acid model with IC50 value of 40.97 µM. It has also shown mild activation effect on CYP 269 and CYP 2C9 enzymes, indicating the usefulness of thiosemicarbazones as anticonvulsants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294704     DOI: 10.2174/187152411794961112

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  1 in total

1.  Influence of Complexation of Thiosemicarbazone Derivatives with Cu (II) Ions on Their Antitumor Activity against Melanoma Cells.

Authors:  Monika Pitucha; Agnieszka Korga-Plewko; Agnieszka Czylkowska; Bartłomiej Rogalewicz; Monika Drozd; Magdalena Iwan; Joanna Kubik; Ewelina Humeniuk; Grzegorz Adamczuk; Zbigniew Karczmarzyk; Emilia Fornal; Waldemar Wysocki; Paulina Bartnik
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.